Company Financials

CureVac N.V. Financials

Euro

business CureVac N.V. Company Profile

Main Stock Listing

FSX: 5CV

Market Capitalization €890.8 Million as of Jan. 1, 2026

Market Cap History

Valuations Metrics as of Jan. 3, 2026

Trailing PE 6.89
Forward PE 0.50
Price to Sales TTM €12.59
Price to Book MRQ €0.82
Enterprise to Revenue 3.84
Enterprise to EBITDA 1.40

Financial Reports as of Sep. 30, 2025

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2025-09-30
Profit Margin 182.11%
Operating Margin 573.04%
Return on Assets TTM 20.20%
Return on Equity TTM 23.28%

Income Statement

Revenue TTM €70,741,000
Revenue per Share TTM €0.44
Quarterly Revenue Growth -89.00%
Gross Profit TTM €65,992,000
EBITDA €208,848,000
Net Income to Common TTM €128,824,000
Diluted EPS TTM €0.57
Quarterly Earnings Growth YoY -19.20%

Balance Sheet

Total Cash MRQ €416,089,984
Total Cash per Share MRQ €2.30
Total Debt MRQ
Total Debt to Equity MRQ 4.03
Current Ratio MRQ 3.70
Book Value per Share MRQ €4.82

Cash Flow

Operating Cash Flow TTM €-120,137,000
Levered Free Cash Flow TTM €162,186,000

5CV Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding 225,172,749
Float Shares 180,774,458
Avg 10 Volume 16,369
Avg 30 Volume None
Shares Short None
Short Ratio
Short % of Shares %
% Held by Insiders 0.10%
% Held by Institutions 10.42%

Stock Price Summary

Beta 1.77
Fifty Two Week Low €2.15
Fifty Two Week High €4.95
Fifty Two Week Change -8.30%
Day 50 MA €4.28
Day 200 MA €4.14

Dividends and Splits

Forward Annual Dividend Rate
Forward Annual Dividend Yield %
Trailing Annual Dividend Rate €0.00
Trailing Annual Dividend Yield 0.00%
Payout Ratio 0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date